At MedReleaf, we understand that healthcare providers depend on evidence to draw medical conclusions. This is why we are working to bring evidence-based results to the world. In partnership with Tikun Olam, MedReleaf is currently involved in a variety of scientific and clinical studies at world-class hospitals and research institutions.
The Endocannabinoid System
Cannabinoids exert many of their pharmacological effects by interacting with and modulating
the human endocannabinoid system. This integrated system is comprised of a family of
cannabinoid receptors, their endogenous activators (ligands), enzymes and transporters.
There are two types of cannabinoid receptors, CB1 and CB2. In addition, cannabinoids interact with other important neurotransmitter and neuromodulatory systems as well as TRP Channels.
The far-reaching pharmacology of cannabinoids explains why they hold such promise in diverse therapeutic areas.